Benzinga - Fri, 26 Mar 2021 08:14:31 -0400
Benzinga - Tue, 09 Mar 2021 06:03:09 -0400
Benzinga - Mon, 08 Mar 2021 13:01:53 -0400
Benzinga - Mon, 08 Mar 2021 09:12:19 -0400
Benzinga - Tue, 02 Mar 2021 08:39:27 -0400
Benzinga - Mon, 08 Feb 2021 06:16:26 -0400
Benzinga - Fri, 05 Feb 2021 13:51:05 -0400
load more
Sector: Health Care.Industry: Biotechnology
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS-0.350-0.340 0.0100
REV60.000K0-60.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ORTXOrchard Therapeutics-3.58%832.5M

Orchard Therapeutics Company Questions & Answers

Q

How do I buy Orchard Therapeutics (ORTX) stock?

A

You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Orchard Therapeutics's (ORTX) main competitors?

A

Other companies in Orchard Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Humanigen (NASDAQ:HGEN) and Aligos Therapeutics (NASDAQ:ALGS).

Q

What is the target price for Orchard Therapeutics?

A

The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by JP Morgan on 2021-03-02. The analyst firm set a price target for 15.00 expecting ORTX to rise to within 12 months (a possible 122.88% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Orchard Therapeutics (ORTX) stock ?

A

The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $6.73 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Orchard Therapeutics (ORTX) dividend?

A

There are no upcoming dividends for Orchard Therapeutics.

Q

When is Orchard Therapeutics (NASDAQ:ORTX) reporting earnings?

A
Orchard Therapeutics’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for ORTX?

A

There is no upcoming split for Orchard Therapeutics.